Skip to main content

Table 1 Characteristics of the evaluated screening scenarios

From: Trade-off between benefits, harms and economic efficiency of low-dose CT lung cancer screening: a microsimulation analysis of nodule management strategies in a population-based setting

Characteristics

Considered variations

Eligibility criteria

Population:

50-74-30-15

Values arranged as

(eligibility criteria of the NLST clinical trial)

age at begin smoking - age at quit smoking - minimum pack years - maximum years since quitting smoking

55-80-30-15

(as recommended by the US Preventive Services Task Force (USPSTF) for lung screening with LDCT [2])

50-75-15-9

(less restrictive eligibility criteria, similar to the NELSON trial)

55-75-40-10

(more restrictive eligibility criteria) [18]

Nodule management algorithm

 

NELSON-like

VDT cut = 400 days – V cut = 500 mm3

Scenario is characterised by the threshold value of the volume doubling time (VDT cut) and the cut-off volume (V cut) for cancer positive

(values of the NELSON clinical trial)

VDT cut = 400 days – VDT cut = 300 mm3

VDT cut = 400 days – VDT cut = 400 mm3

VDT cut = 400 days – VDT cut = 750 mm3

VDT cut = 300 days – VDT cut = 500 mm3

VDT cut = 600 days – VDT cut = 500 mm3

VDT cut = 300 days – omitting VDT cut a

VDT cut = 400 days – omitting VDT cut a

VDT cut = 600 days – omitting VDT cut a

V fup = 80 mm3 – VDT cut = 400 days – VDT cut = 500 mm3 b

NLST-like

Growth cut = 10% – D cut = 10 mm

Scenario is characterised by the threshold value of the tumour growth and the diameter (D cut) for cancer positive

(values of the NLST clinical trial)

Growth cut = 10% – D cut = 9 mm

Growth cut = 10% – D cut = 11 mm

Growth cut = 7.5% – D cut = 10 mm

Tumour growth (threshold growth, Growth cut) is defined as a percentage increase in diameter

Growth cut = 12.5% – D cut = 10 mm

Growth cut = 7.5% – omitting D cut a

Growth cut = 10% – omitting D cut a

Growth cut = 12.5% – omitting D cut a

D fup = 5 mm – Growth = 10% – D cut = 10 mmb

  1. aIn these scenarios nodule growth is taken as a single malignancy predictor
  2. bIn these scenarios a higher nodule size for the follow-up exams (V fup; D fup) is used according to the British Thoracic Society guidelines [29]. In other scenarios the value of nodule size for follow-up exams is applied according to the trials as 4 mm (NLST-like) and 50 mm3 (NELSON-like)